DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Astec LifeSciences Limited — Spurt in Volume

NSE 39 min ago·9 Sept 2026, 5:19 am

Astec Lifesciences

Astec LifeSciences Limited has reported a significant increase in trading volume on the stock exchange. In response to a query from the exchange regarding this surge, the company has submitted its official explanation to the market.

This development is noteworthy as it signals heightened investor interest in the stock. While the company has provided a response, the specific reasons for the volume spike remain to be seen. Investors are advised to monitor the company's official disclosures to understand the context behind this activity.

Moving forward, market participants should watch for any further clarifications from Astec LifeSciences. Understanding the drivers behind this volume spurt will be key to assessing its impact on the stock's short-term price movement.